Nizatidine
Product Images NDC 21695-043

2 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nizatidine (NDC 21695-043). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nizatidine Chemical Structure (487b4138 F7db 480f 96d2 8010fd5c0c06 01)

Nizatidine Chemical Structure (487b4138 F7db 480f 96d2 8010fd5c0c06 01)
Chemical structure of Nizatidine displaying its molecular framework, including sulfur and nitrogen atoms. The image includes the molecular formula C12H21N5O2S2 and molecular weight 331.46.*
FDA Label Image

Nizatidine 300mg (487b4138 F7db 480f 96d2 8010fd5c0c06 02)

Nizatidine 300mg (487b4138 F7db 480f 96d2 8010fd5c0c06 02)
Nizatidine 300 mg capsules label from Physician Partner, a division of Rebel Distributors Corp, with a package size of 30 capsules. The label identifies the active ingredient as Nizatidine USP 300 mg per capsule. The capsules are described as light brown opaque with specific imprint codes. Manufacturer is Watson Pharma Private Limited, India. The label includes storage instructions and safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.